Immunohistochemical examination of CD5, lambda, and kappa expressions revealed that the primary tumor was positive for CD5 (Figure 3A), kappa (Figure 3C), and lambda (Figure 3E), but the recurrent tumor was weakly positive for CD5 (Figure 3B) and kappa (Figure 3D). The gene discussed is CD5; the disease is neoplasm.